INVIRASE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Invirase, and when can generic versions of Invirase launch?
Invirase is a drug marketed by Hoffmann La Roche and Hoffmann-la Roche and is included in two NDAs.
The generic ingredient in INVIRASE is saquinavir mesylate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the saquinavir mesylate profile page.
Summary for INVIRASE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 12 |
Patent Applications: | 4,134 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for INVIRASE |
What excipients (inactive ingredients) are in INVIRASE? | INVIRASE excipients list |
DailyMed Link: | INVIRASE at DailyMed |
Recent Clinical Trials for INVIRASE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hoffmann-La Roche | Phase 1 |
Hoffmann-La Roche | Phase 2 |
National Institutes of Health (NIH) | Phase 2/Phase 3 |
Pharmacology for INVIRASE
Drug Class | Protease Inhibitor |
Mechanism of Action | Cytochrome P450 3A Inhibitors HIV Protease Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for INVIRASE
US Patents and Regulatory Information for INVIRASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hoffmann La Roche | INVIRASE | saquinavir mesylate | CAPSULE;ORAL | 020628-001 | Dec 6, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hoffmann-la Roche | INVIRASE | saquinavir mesylate | TABLET;ORAL | 021785-001 | Dec 17, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for INVIRASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hoffmann La Roche | INVIRASE | saquinavir mesylate | CAPSULE;ORAL | 020628-001 | Dec 6, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Hoffmann-la Roche | INVIRASE | saquinavir mesylate | TABLET;ORAL | 021785-001 | Dec 17, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for INVIRASE
See the table below for patents covering INVIRASE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Lithuania | 3682 | METHOD FOR PREPARING AMINO ACID DERIVATIVES AND PHARMACEUTHICAL COMPOSITIONS THEREOF | ⤷ Try a Trial |
Monaco | 2195 | ⤷ Try a Trial | |
African Intellectual Property Organization (OAPI) | 9334 | ⤷ Try a Trial | |
China | 1034805 | ⤷ Try a Trial | |
Norway | 905322 | ⤷ Try a Trial | |
Canada | 2030433 | DERIVES D'ACIDE AMINE (NEW ISOQUINOLINE- CARBOXAMIDE AMINO ACID DERIVATIVES USEFUL FOR TREATMENT OF VIRAL DISEASES) | ⤷ Try a Trial |
Japan | H03255076 | AMINO ACID DERIVATIVE | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for INVIRASE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0432695 | 32/1996 | Austria | ⤷ Try a Trial | PRODUCT NAME: SAQUINAVIR UND SEINE SAEUREADDITIONSSALZE, INSBESONDERE SAQUINAVIRMESYLAT; REGISTRATION NO/DATE: EU/1/96/026/001 19961004 |
0432695 | 96C0044 | Belgium | ⤷ Try a Trial | PRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004 |
0432695 | C970013 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: SAQUINAVIR DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARD BAAR ZUURADDITIEZOUT, IN HET BIJZONDER HET MESYLAAT; REGISTRATION NO/DATE: EU/1/96/026/001 19961004 |
0034432 | 96C0048 | Belgium | ⤷ Try a Trial | PRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |